Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Factors influencing the prescription of allergen immunotherapy: the allergen immunotherapy decision analysis (AIDA) study.
Frati F, Incorvaia C, Cadario G, Fiocchi A, Senna GE, Rossi O, Romano A, Scala E, Romano C, Ingrassia A, Zambito M, Dell'albani I, Scurati S, Passalacqua G, Canonica GW; AIDA Study Group. Frati F, et al. Among authors: ingrassia a. Eur Ann Allergy Clin Immunol. 2013 Oct 1;45 Suppl 2:11-6. Eur Ann Allergy Clin Immunol. 2013. PMID: 24129083
Evaluation of two commercial peach extracts for skin prick testing in the diagnosis of hypersensitivity to lipid transfer protein. A multicenter study.
Asero R, Aruanno A, Bresciani M, Brusca I, Carollo M, Cecchi L, Cortellini G, Deleonardi G, Farsi A, Ferrarini E, Gabrielli G, Ingrassia A, Mauro M, Murzilli F, Nucera E, Onida R, Pastorello EA, Pinter E, Rizzi A, Russello M, Sacerdoti C, Scala E, Scala G, Villalta D, Zampogna S, Amato S, Mistrello G. Asero R, et al. Among authors: ingrassia a. Eur Ann Allergy Clin Immunol. 2021 Jul;53(4):168-170. doi: 10.23822/EurAnnACI.1764-1489.144. Epub 2020 Apr 29. Eur Ann Allergy Clin Immunol. 2021. PMID: 32347686 Free article.
Sensitization to Gibberellin-Regulated Protein (Peamaclein) Among Italian Cypress Pollen-Sensitized Patients.
Asero R, Abbadessa S, Aruanno A, Barilaro G, Barzaghi C, Bignardi D, Bilò MB, Borro M, Bresciani M, Busa M, Buzzulini F, Cavaliere C, Cecchi L, Ciccarelli A, Cortellini G, Cucinelli F, Deleonardi G, Emiliani F, Farsi A, Ferrarini E, Franchini M, Ingrassia A, Lippolis D, Losappio L, Marra AM, Martini M, Masieri S, Mauro M, Mazzolini M, Muratore L, Murzilli F, Nucera E, Pastorello EA, Pinter E, Polillo BR, Pravettoni V, Quercia O, Rizzi A, Russello M, Sacerdoti C, Scala E, Scala G, Scarpa A, Schroeder J, Uasuf CG, Villalta D, Yang B, Mistrello G, Amato S, Lidholm J. Asero R, et al. Among authors: ingrassia a. J Investig Allergol Clin Immunol. 2021 Feb 21;32(1):40-47. doi: 10.18176/jiaci.0542. Epub 2021 Jul 30. J Investig Allergol Clin Immunol. 2021. PMID: 32732184 Free article.
Altered TFEB subcellular localization in nigral neurons of subjects with incidental, sporadic and GBA-related Lewy body diseases.
Moors TE, Morella ML, Bertran-Cobo C, Geut H, Udayar V, Timmermans-Huisman E, Ingrassia AMT, Brevé JJP, Bol JGJM, Bonifati V, Jagasia R, van de Berg WDJ. Moors TE, et al. Among authors: ingrassia amt. Acta Neuropathol. 2024 Apr 6;147(1):67. doi: 10.1007/s00401-024-02707-z. Acta Neuropathol. 2024. PMID: 38581586 Free PMC article.
Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial.
Di Stadio A, Gallina S, Cocuzza S, De Luca P, Ingrassia A, Oliva S, Sireci F, Camaioni A, Ferreli F, Mercante G, Gaino F, Pace GM, La Mantia I, Brenner MJ. Di Stadio A, et al. Among authors: ingrassia a. Eur Arch Otorhinolaryngol. 2023 Nov;280(11):4949-4961. doi: 10.1007/s00405-023-08085-8. Epub 2023 Jun 28. Eur Arch Otorhinolaryngol. 2023. PMID: 37380908 Free PMC article. Clinical Trial.
51 results